# Circulating Tumor DNA in Peripheral T-cell Lymphomas

> **NCT06362148** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Aarhus** · enrollment: 50 (estimated)

## Conditions studied

- Peripheral T-cell Lymphoma
- NK/T-Cell Lymphoma

## Interventions

- **DIAGNOSTIC_TEST:** Tumor- and plasma-informed, next-generation sequencing (NGS)-based patient-specific droplet digital (dd)PCR assay
- **DIAGNOSTIC_TEST:** 18F-fludeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)

## Key facts

- **NCT ID:** NCT06362148
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362148, "Circulating Tumor DNA in Peripheral T-cell Lymphomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06362148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*